Medical Cannabis & Mito

Join MitoAction and Dr. Fran Kendall of VMP Genetics on May 1 for our May Monthly Mito Expert Series!

Her topic will be: Medical Cannabis & Mito: Historical Perspectives, Mechanism of Action and Other Need to Knows.

About the Speaker

Dr. Fran Kendall is one of the pioneers in the field and is a Harvard-trained board-certified Clinical Biochemical Geneticist who founded the very first clinical mitochondrial disease program in the United States. Over decades of a career specializing in Metabolic, Mitochondrial, and Inherited Disorders, she: founded one of the first commercial laboratories focused on rare metabolic and mitochondrial disorders; pioneered telemedicine and private practice in rare genetics by founding VMP Genetics which has branched into 3 divisions (Direct Patient Care, Education, Physician to Physician Support); was the head of genetics for a large hospital system; authored chapters on mitochondrial medicine for medical texts and numerous research articles; lectures at medical schools and nursing schools on these disorders; is a frequent guest speaker at medical conferences on mitochondrial disease and autism; often acts as an expert witness in Federal court cases; and has appeared on national news outlets to offer expert opinion.

She currently sees children and adult patients from around the world in either her VMP Genetics clinic offices in Atlanta, GA or by telemedicine.

Date: 05/01/2020
Speaker: Dr. Fran Kendall
Listen Now: Click Here
View Slides: Click Here

Related Articles

PTC743 (Vatiquinone) for the Treatment of Mitochondrial Disease With Associated Epilepsy
Date: 11/06/2020
Speaker: Matt Klein & Francesco Bibbiani
Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian
Date: 07/25/2020
Speaker: Camille Bedrosian & Bridget Reineking
Acylcarnitines: What are They and What Do They Mean?
Date: 07/25/2020
Speaker: Dr. Melanie Gillingham